par Suppa, Mariano 
;Benhadou, Farida ;Daxhelet, Mathilde ;Del Marmol, Véronique
Référence Revue médicale de Bruxelles, 39, 4, page (367-371)
Publication Publié, 2018-09
;Benhadou, Farida ;Daxhelet, Mathilde ;Del Marmol, Véronique Référence Revue médicale de Bruxelles, 39, 4, page (367-371)
Publication Publié, 2018-09
Article révisé par les pairs
| Résumé : | Hidradenitis suppurativa (HS) is a chronic cutaneous disease with a prevalence ranging between 0.05 % and 4 % in the general population. The clinical presentation features painful inflammatory nodules on the apocrine gland-bearing body regions, evolving later on in fluctuant abscesses, fistulas and hypertrophic scars. HS represents a significant burden for the patients, severely limiting their quality of life. The disease is still relatively unknown by physicians the time-to-diagnose can be extremely long and the therapeutic measures available are currently limited. In this paper we review the medical and surgical options for HS with a particular focus on recent, new therapeutic approaches. |
